Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Lik-Yuen Chan

Showing results (1-10 of 297) with videos related to

Pageof 30
Sort By:
The Lancet. Infectious Diseases|February 1, 2021
Debate settled for elevated alanine aminotransferase in hepatitis B?Henry Lik-Yuen Chan
Gastroenterology|March 28, 2012
Identifying hepatitis B carriers at low risk for hepatocellular carcinomaHenry Lik-Yuen Chan
Journal of Gastroenterology and Hepatology|December 24, 2010
JGH Foundation emerging leadership lecture. Significance of hepatitis B virus genotypes and mutations in the development of hepatocellular carcinoma in AsiaHenry Lik-Yuen Chan
Hepatology (Baltimore, Md.)|July 21, 2020
Letter to the Editor: Use of Pregenomic Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen to Predict Cure of Hepatitis B Virus InfectionHenry Lik-Yuen Chan
Hepatology International|July 24, 2015
Are we ready to use the hepatitis B surface antigen level to guide peginterferon treatment in HBeAg-negative chronic hepatitis B?Henry Lik Yuen Chan
Journal of Gastroenterology and Hepatology|November 8, 2018
Okuda lecture: Challenges of hepatitis B in the era of antiviral therapyHenry Lik Yuen Chan
Gut|September 4, 2012
Peginterferon therapy for chronic hepatitis B: one size fits all?Henry Lik-Yuen Chan
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|August 31, 2024
Is HBV RNA a new endpoint of HBV cure?Henry Lik Yuen Chan
Journal of Gastroenterology and Hepatology|February 23, 2012
Response-guided therapy by hepatitis B surface antigen level for peginterferon therapy: what is next?Henry Lik-Yuen Chan
Digestive Diseases and Sciences|May 12, 2010
Antiviral therapy for acute-on-chronic liver failure in chronic hepatitis B: is it too late?Henry Lik-Yuen Chan
Pageof 30

Showing results (1-10 of 297) with videos related to

Sort By:
Pageof 30
The Lancet. Infectious Diseases|February 1, 2021
Debate settled for elevated alanine aminotransferase in hepatitis B?Henry Lik-Yuen Chan
Gastroenterology|March 28, 2012
Identifying hepatitis B carriers at low risk for hepatocellular carcinomaHenry Lik-Yuen Chan
Journal of Gastroenterology and Hepatology|December 24, 2010
JGH Foundation emerging leadership lecture. Significance of hepatitis B virus genotypes and mutations in the development of hepatocellular carcinoma in AsiaHenry Lik-Yuen Chan
Hepatology (Baltimore, Md.)|July 21, 2020
Letter to the Editor: Use of Pregenomic Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen to Predict Cure of Hepatitis B Virus InfectionHenry Lik-Yuen Chan
Hepatology International|July 24, 2015
Are we ready to use the hepatitis B surface antigen level to guide peginterferon treatment in HBeAg-negative chronic hepatitis B?Henry Lik Yuen Chan
Journal of Gastroenterology and Hepatology|November 8, 2018
Okuda lecture: Challenges of hepatitis B in the era of antiviral therapyHenry Lik Yuen Chan
Gut|September 4, 2012
Peginterferon therapy for chronic hepatitis B: one size fits all?Henry Lik-Yuen Chan
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|August 31, 2024
Is HBV RNA a new endpoint of HBV cure?Henry Lik Yuen Chan
Journal of Gastroenterology and Hepatology|February 23, 2012
Response-guided therapy by hepatitis B surface antigen level for peginterferon therapy: what is next?Henry Lik-Yuen Chan
Digestive Diseases and Sciences|May 12, 2010
Antiviral therapy for acute-on-chronic liver failure in chronic hepatitis B: is it too late?Henry Lik-Yuen Chan
Pageof 30